About Erudio Bio, Inc.
Erudio Bio is a biotech company that powers AI drug discovery with ground-truth binding data through its Versatile Smart Assay (VSA) and bioTCAD platform, enabling faster and more reliable preclinical drug design.
AI drug discovery with ground-truth binding dataMultiplex force-spectroscopy binding measurementsComprehensive binding data including strength and kineticsScalable data generation with VSA (50-100 interactions per run from ~10 L samples)Reduction of wet-lab cycles and de-risking of drug candidates
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Erudio Bio, Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.